Early initiation of moderate-intensity aerobic exercise reduced pain compared with standard care among postmenopausal women who received aromatase inhibitors.
In the case of breast cancer, women with a higher BMI do have higher rates of recurrence compared to women in the "normal" ...
Recent advancements in endometriosis research are transforming treatment, focusing on non-surgical interventions and ...
This study reveals that Fe-doped boron nitride nanoparticles improve Anastrozole delivery, offering enhanced stability and targeted therapy for breast cancer.
It is administered orally and is prescribed in combination with an aromatase inhibitor as an initial endocrine-based therapy. Additionally, the drug is being developed for the treatment of ...
As our knowledge about aromatase inhibitors and their side effects has expanded, questions remain unanswered with regards to their influence on cognition. Future study designs evaluating cognitive ...
Among those who received endocrine therapy, 31.8% used tamoxifen and 47.8% used aromatase inhibitors. Researchers compared women’s physical health before their breast cancer diagnosis and at 3 ...
Aromatase inhibitors (AIs) such as anastrozole, letrozole and exemestane are used as adjuvant treatment for postmenopausal women with hormone receptor-positive breast cancer. The interindividual ...
State Key Laboratory of Natural Medicines, Department of Organic Chemistry, China Pharmaceutical University, Nanjing 210009, China ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback